The Patent Finder
US

Hydroxypropyl Beta-Cyclodextrin Compositions and Methods

US 10,258,641 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Oct 8, 2025 (Hercules Capital, Inc.).

Term ends Jun 9, 2036 · High confidence

Held by Mandos LLC
Filed Apr 27, 2017 as application 15/499,831 · Granted Apr 16, 2019
Base term, 20 years from filing
Today
20 years from filing
2016 2036
Clock starts
Jun 9, 2016
Term ends
Jun 9, 2036
Granted
Apr 16, 2019
base term fee events Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,675,634, to Jun 9, 2036. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
49
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 9, 2016, when application 15/178,153, the earliest non-provisional in its chain, was filed (this one was filed Apr 27, 2017)Jun 9, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 9,675,634)resolves to Jun 9, 2036, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJun 9, 2036High confidence

This family

Application 15/178,153Abandoned
not computed
not computed
US 9,675,634In force
Jun 2036
Jun 2036
US 10,258,641this patent
Jun 2036
Jun 2036
US 10,300,086In force
Jun 2036
Jun 2036
US 10,709,730In force
Jun 2036
Jun 2036
US 10,933,083In force
Jun 2036
Jun 2036
US 11,406,657In force
Jun 2036
Jun 2036
US 11,541,074In force
Jun 2036
Jun 2036
8 of 49 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Oct 26, 2017
Reel 43960, frame 862
Machielse, Bernardus Nicolaas; Darling, AllanVtesse, Inc.Assignment of Assignor's Interest
Oct 31, 2017
Reel 43994, frame 850
Vtesse Inc.JPMorgan Chase Bank, N.A., as Administrative AgentSecurity Interest
Feb 13, 2018
Reel 44909, frame 699
JPMorgan Chase Bank, N.A., as Administrative AgentVtesse Inc.Release of Security Interest
Feb 13, 2018
Reel 45314, frame 654
Vtesse Inc.Deutsche Bank AG New York Branch, as Collateral AgentNotice of Grant of Security Interest in Intellectual Property
Dec 10, 2019
Reel 51256, frame 829
Mallinckrodt Ard IP Limited; Mallinckrodt Hospital Products IP Limited; Specgx LLC; Ocera Therapeutics, Inc.; Mallinckrodt Pharma IP Trading Designated Activity Company; Stratatech Corporation; Vtesse Inc.; Mallinckrodt LLCWilmington Savings Fund Society, FSB, as Second Lien Collateral AgentSecurity Interest
Jul 15, 2021
Reel 56872, frame 369
Vtesse LLCMandos LLCAssignment of Assignor's Interest
Jun 17, 2022
Reel 60389, frame 839
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentOcera Therapeutics, Inc.; Mallinckrodt LLC; Mallinckrodt Ard IP Unlimited Company (F/K/A Mallinckrodt Ard IP Limited); Mallinckrodt Hospital Products IP Unlimited Company (F/K/A Mallinckrodt Hospital Products IP Limited); Mallinckrodt Pharma IP Trading Unlimited Company (F/K/A Mallinckrodt Pharma IP Trading Designated Activity Company); Specgx LLC; Stratatech Corporation; Vtesse LLC (F/K/A Vtesse Inc.)Release of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentOcera Therapeutics, Inc.Release of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentMallinckrodt LLCRelease of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentMallinckrodt Ard IP Unlimited Company (F/K/A Mallinckrodt Ard IP Limited)Release of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentMallinckrodt Hospital Products IP Unlimited Company (F/K/A Mallinckrodt Hospital Products IP Limited)Release of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentMallinckrodt Pharma IP Trading Unlimited Company (F/K/A Mallinckrodt Pharma IP Trading Designated Activity Company)Release of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentSpecgx LLCRelease of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentStratatech CorporationRelease of Security Interest
Jun 17, 2022
reel/frame not recorded
Wilmington Savings Fund Society, FSB, as Second Lien Collateral AgentVtesse LLC (F/K/A Vtesse Inc.)Release of Security Interest
Jul 14, 2025
Reel 71937, frame 425
Deutsche Bank AG New York BranchVtesse Inc.Release of Security Interest
Oct 8, 2025
Reel 73056, frame 214
Beren Therapeutics P.B.C.; Mandos LLCHercules Capital, Inc., as AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited